There have been several notable achievements of the Ministry of Health & Family Welfare during 2014.
These are enumerated below:
Department of Health &Family Welfare
1. National Health Mission
Under NHM, there have been significant improvements in health outcomes in terms of mortality rates as well as improvements in service delivery in health facilities. But the most important has been eradication of polio from the country.
Eradication of Polio
India has reported no polio case for the last more than three years and has also been certified as ‘Polio-free’ by WHO in 2014. This is monumental considering that India accounted for over 50 percent of the world’s polio incidence in 2009.
Improvements in Health Outcomes
Improvements in Health Service Delivery
(Between 2009-10 to 2013-14 )
Increased Public Health Spending
Infrastructure Upgradation
Human Resources
Accredited Social Health Activist (ASHA)
National Mobile Medical Unit Services
National Ambulance Services
– 108 is emergency response system, primarily designed to attend to patients of critical care, trauma and accident victims etc.
– 102 services essentially consist of basic patient transport aimed to cater the needs of pregnant women and children though other categories are also taking benefit and are not excluded. JSSK entitlements e.g. free transfer from home to facility, inter facility transfer in case of referral and drop back for mother and children are the key focus of 102 service.
National Free Drugs Service Initiative
High Priority Districts
Universal Health Coverage Pilots
Improving Quality
Maternal & Child Tracking System (MCTS) & Mother and Child Tracking Facilitation Centre (MCTFC)
Reproductive, Maternal, Newborn, Child and Adolescent Health services (RMNCH+A) –
A Continuum of care approach has been adopted under NHM with the articulation of ‘Strategic approach to Reproductive Maternal, Newborn, Child and Adolescent health (RMNCH+A) in India, bringing focus on all the life stages, notably the adolescents. Under this approach, the following major interventions are implemented:
Rashtriya Kishor Swasthya Karyakram (RKSK), a new initiative was launched on 7th January 2014 to reach out to 253 million adolescents in the country. RKSK seeks to reach adolescents in their own spaces and introduces peer-led interventions at the community level, supported by augmentation of facility based services. This initiative broadens the focus of the adolescent health programme beyond reproductive and sexual health and brings in focus on life skills, nutrition, injuries and violence (including gender based violence), non-communicable diseases, mental health and substance misuse.
2. National Health Assurance Mission
The Government is considering rolling out of a National Health Assurance Mission. This is a novel step in that it looks at and seeks to address health needs comprehensively as a continuum. The proposed Mission seeks to improve health outcomes, reduce avoidable death and disease, and reduce high Out of Pocket Expenditures and impoverishment on account of expenditure on healthcare. The key components of the proposed Mission include preventive and promotive health care, assured access to free essential drugs, assured access to free essential diagnostics, assured health care services that include comprehensive primary health care and assured secondary care as a continuum with primary care and assured select tertiary care services. This would be supplemented by access to free ambulance service and emergency care. The draft memorandum on the proposed NHAM for approval of the Expenditure Finance Committee (EFC) Memo has been prepared and has been circulated for comments of Ministries.
3. Indian Newborn Action Plan (INAP)
The India Newborn Action Plan (INAP) was launched on September 18. It is India’s first commitment to end preventable newborn deaths. It also identifies ways to accelerate progress and scale up interventions that are high-impact and cost-effective, driven by epidemiological causes. India strives to achieve single-digit newborn mortality rate by 2030. INAP has been designed in response to the Global Every Newborn Action Plan launched at the 67th World Health Assembly in June 2014.
4. Integrated Diarrhoea Control Fortnight (IDCF)
IDCF will lead to avoiding 11 percent of cases of child mortality. It was launched on July 28, 2014 across all 36 states and union territories. During the first week the focus was on oral rehydration and Zinc, while the second week was used for highlighting the goodness of breastfeeding and appropriate nutrition. It involved home visits by frontline workers, counselling and demonstration. The Ministry of Women and Child Development, Departments of School Education, and Water and Sanitation participated in the effort.
5. National Tobacco Control Programme
(1) The Ministry of Health & Family Welfare in collaboration with World Health Organization commissioned a study titled “Economic Burden of Tobacco Related Diseases in India” (2014). The study mapped the estimated direct and indirect cost of four tobacco use attributable diseases namely cardio-vascular diseases, cancer, tuberculosis and respiratory diseases, and found that the total economic costs attributable to tobacco use from all the four diseases in India in the year 2011 for persons aged 35-69 years amounted to Rs. 1,04,500 crores. This estimated cost is 1.16% of the GDP and is 12 % more than the combined state and central government expenditures on health in 2011-12.
(2) The Food Safety and Standards (Prohibition and Restrictions on Sales) Regulations, 2011 dated 1st August 2011, issued under the Food Safety and Standards Act, 2006 lays down that tobacco and nicotine shall not be used as ingredients in any food products. Currently, 34 states / UTs have issued orders for implementation of the Food Safety Regulations banning manufacture, sale and storage of Gutka and Pan Masala containing tobacco or nicotine. The Ministry has also written to all the states to consider issuing necessary notification under the Food Safety & Standards Act 2006 to implement the ban on all forms of processed /flavoured/scented chewing tobacco, whether going by the name or form of gutkha, zarda etc.
(3) The Ministry of Health & Family Welfare organized a roundtable in July, 2014 to discuss the current evidence around the existing and potential impact of Electronic Nicotine Delivery Systems (ENDS) on public health, explore global efforts in combating ENDS and decide measures as appropriate for India.
(4) The Ministry has consistently advocated for higher taxes and reduction of duty free allowance on all tobacco products. This led to following action in the Union Budget for 2014- 15:
ü Increase in Excise Duty
ü Reduction in duty free allowance
(5) Ministry notified the new rules on tobacco pack pictorial warnings on 15th October, 2014, to come into effect from 1st April, 2015. The new rules mandate display of pictorial health warnings on 85% of principal display area of tobacco packs on both sides. With this notification, India has moved from 136thrank to the 1st position on the global level for this important public health measure.
(6) A Committee has been constituted to review and suggest amendments to the Cigarettes and other Tobacco Products (prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply and Distribution) Act, 2003 (COTPA). The Committee has made a number of recommendations with regard to, inter alia, prohibition of smoking in public place, advertisements at point of sale, minimum legal age for sale of tobacco products, loose sale of tobacco products, depiction of tar and nicotine contents and the penal provisions etc. A draft note has been prepared for the Cabinet and circulated for inter- ministerial consultation.
(7) An Inter-ministerial Committee of Secretaries has been constituted at the national level under the chairpersonship of the Cabinet Secretary to review and develop a comprehensive policy on tobacco and tobacco related issues.
6. Pradhan Mantri Swasthya Suraksha Yojana (PMSSY)
The Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) has been launched with the objectives of correcting regional imbalances in the availability of affordable/reliable tertiary healthcare services and to also augment facilities for quality medical education in the country. PMSSY has two components – setting up of AIIMS like institutions and upgradation of State Government Medical Colleges.
In first phase, six AIIMS are being set up, one each at Bhopal, Bhubaneswar, Jodhpur, Patna, Raipur and Rishikesh. Two more AIIMS, one each in Uttar Pradesh and West Bengal have been approved. Simultaneously, 19 existing Government Medical College Institutions have been undertaken for upgradation for creation of super speciality facilities in the first and second phases of PMSSY. In addition, it has also been decided to take up upgradation of 39 more medical college in the third phase of PMSSY, and 12 government medical colleges under fourth phase of PMSSY.
7. Medical education
A total of 17 new Medical Colleges and 8 new Dental Colleges have been established. There has been an increase in intake capacity: 2750 MBBS seats and 1120 BDS seats. With the intervention of the Minister for Health & Family Welfare, there has been renewal of 4747 seats restored in case of 73 Government Medical Colleges. In addition, there has been increase in intake capacity of Postgraduate seats by 1150 seats.
MoUs have been signed with 18 States/UTs under the scheme for ‘Establishment of new Medical Colleges attached with existing District/ Referral hospitals’. In addition, 127 ANM and 137 GNM Schools have been approved in 29 States.
8. Ebola surveillance
Heightened surveillance and tracking systems have been put in place at India’s air and sea ports after World Health Organisation (WHO) put out an international alert on 8th August 2014 against Ebola Virus Disease. Over 100 samples have been tested at these two laboratories using RT PCR test. Ten additional laboratories have been identified by Indian Council of Medical Research (ICMR) for testing Ebola Virus Disease, and are ready to test samples. Moreover, about 9500 Personal Protective Equipment (PPE) kits have been provided to the states by the Medical Store Organization. The Health Ministry has conducted separate trainings for Master Trainers and the State Rapid Response Teams (RRT) of all states for public health preparedness and response to Ebola Virus disease. Master Trainers from 25 states and Rapid Response Teams of all the states/UTs have been trained through four Regional Training Workshops.
Till date not a single Ebola case has been found in India.
9. Drug resistant survey for 13 TB drugs launched
Biggest ever drug resistant survey in the world for 13 TB drugs launched, results expected in a year’s time. The nationwide drug resistance survey (DRS) will provide RNTCP with a better estimate on the burden of Multi-Drug Resistant Tuberculosis in the community. As part of the survey, the samples will be subjected to susceptibility testing for 13 anti-TB drugs (5 first line drugs and 8 second line drugs).
10. National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke
A total of 364 districts have been taken up for implementation by the end of financial year 2014- 15.
Ø State NCD Cell established in 26 states.
Ø District NCD Cell established in 142 districts.
Ø District NCD Clinic established in 147 districts.
Ø Cardiac Care Units have been established in 65 districts
As on 31-03-2014 total of 5,57,39,571 persons have been screened for Diabetes and Hypertension respectively. Of these, 6.15% are suspected to be Diabetes and 5.12% found to be hypertensive or pre hypertensive.
11. Country’s first National Mental Health Policy launched
The Ministry launched the country’s first ever Mental Health Policy in October 2014. The Policy’s objective is to provide universal access to mental health care by enhancing understanding of mental health and strengthening leadership in the mental health sector at all levels. It clearly spells out the specific roles to be played by the central government, state governments, local bodies and civil society organisations.
12. Steps against Japanese Encephalitis (JE) and Acute Encephalitis Syndrome (AES)
The Ministry of Health launched a 100 percent vaccination drive against JE in Muzaffarpur district, Bihar through a two-day camp on 22-23 June, 2014. To combat AES, the Ministry removed all bottlenecks to set up facilities for concentrated care of patients in the government hospitals of the affected districts.
13. Introduction of new vaccines against preventable diseases
On July 3, the Prime Minister announced expansion of India’s Universal Immunisation Programme (UIP) to cover four more diseases – Rotavirus, Rubella, Polio and adult cases of Japanese Encephalitis. This will cover 2.7 crore children and give momentum to India’s aim of achieving Millennium Development Goal (MDG-4) targets that include reducing child mortality.
14. Kala Azar elimination drive
On 22 August, 2014 a new thrust was adopted for the elimination for Kala Azar, a disease endemic in Bihar, Jharkand, West Bengal and Uttar Pradesh. The new plan lists activities, timelines and responsibilities. The Ministry has planned to work elimination of Kala Azar by 2015.
15. Elimination of Filariasis
The Ministry is geared towards elimination of Lymphatic Filariasis by 2015. Efforts are targeted to achieve 80% coverage of targeted population during Mass Drug Administration which has been launched in 250 endemic districts.
16. National Organ Transplant Programme
National Organ and Tissue Transplant Organisation (NOTTO) have been set up at Safdarjung Hospital, New Delhi.
A Cadaver Organ Retrieval Operation Theatre has been constructed at Safdarjung Hospital.
Formats for Donor Pledge, Hospital Registration System, Patient Registration, Kidney Transplant have been prepared.
17. Trauma and burns
Total of 13 additional Trauma Centres on National/State Highways have been approved for funding. While, 17 Burn Units in Medical Colleges approved for support.
18. National Programme for Control of Blindness
The National Programme for Control of Blindness was launched in the year 1976 as a 100% Centrally Sponsored scheme with the goal to reduce the prevalence of blindness from 1.4% to 0.3% by 2020.
Achievements:
19. Central Government Health Scheme (CGHS)
On 1 September, 2013 twenty six CGHS wellness centres in Delhi were opened every day from 1.30 pm to 3 pm to senior citizens for OPD consultation as a pilot project to make the service more inclusive.
Details of payments made to empanelled hospitals and diagnostic centres in preceding month are being placed on CGHS website.
Notification of new hospitals and diagnostic labs and revised rates completed in Delhi and NCR on 1.10.2014 and 12.11.2014- 229 hospitals and 59 diagnostic labs notified.
Notification of new hospitals and diagnostic labs completed in other cities by 17.11.2014 (except Mumbai, Shillong and Lucknow. No e-tender issued in Mumbai; no bidders in Shillong, no technically qualified bidders in Lucknow-existing facilities continuing in those ‘3’ cities).
File Tracking System (FTS) implemented up to Zonal offices under CGHS, Delhi.
Online processing of hospital bills started in Delhi.
20. Development of Allied Health Sciences
The Government has taken steps to initiate the process of setting up a Centrally Sponsored Scheme for establishment of one National Institute of Allied Health Sciences (NIAHS) and eight Regional Institute of Allied Health Sciences (RIAHS).
The Scheme aims to augment the supply of skilled Allied Health manpower and promote their training through standardization of such education/ courses across the country.
This capacity building scheme will also lead to:-
The Government has also initiated steps for establishment of the ‘National Board for Allied Health Sciences’ for standardization of Allied Health education.
In another scheme namely ‘Strengthening/ up-gradation of Pharmacy Institutions and Continuing Education Programme for faculty and practicing pharmacists’ the Government is taking steps to strengthen/ upgrade Pharmacy Institutes along with faculty development programmes and training for practicing Pharmacists.
21. Food standards and safety
With the objective to consolidate the laws relating to food and for laying down science based standards for articles of food and to regulate their manufacture, storage, distribution, sale and import, to ensure availability of safe and wholesome food for human consumption and for matters connected therewith or incidental thereto, the Food Safety and Standards Act was enacted, and the Food Safety and Standards Authority of India (FSSAI) was established in the year 2008.
The following activities were undertaken during this year:
i) Online payment Gateway System for food licensing started from 01/04/2014.
ii) Draft notification dated 2/6/2014 for amending Food Safety and Standards (Food Products Standards and Food additives) Regulations, 2011 relating to use of Encapsulation Ferrous Fumarate and additives for Double Fortified Salt, issued for seeking public comments.
iii) Final Notification dated 10.6.2014 of FSS (Licensing and Registration of Food Businesses) Amendment Regulations, 2014 for extending the time line upto 04.08.2014 for Food Business Operators seeking conversion/renewal of existing licence/registration under repealed Act/order
iv) Time for the Food Business Operators seeking conversion/renewal of existing licence/registration under repealed Act/orders, extended up to 04.02.2015 in August, 2014.
v) Draft notification dated 25/8/2014 for amending Food Safety and Standards (Food Products Standards and Food additives) Regulations, 2011 relating to use of Aspartame and Acesulfame salt, issued for seeking public comments.
vi) Draft notification dated 28/8/2014 for amending Food Safety and Standards (Food Products Standards and Food additives) Regulations, 2011 regarding use of Glucose Oxidase, Lipase and Xylanase as processing in food products, issued for seeking public comments.
vii) Draft notification dated 17/10/2014 for amending Food Safety and Standards (Food Products Standards and Food additives) Regulations, 2011 regarding use of Pullulan as food additives in various food, issued for seeking public comments.
viii) Draft notification dated 11/11/2014 for amending Food Safety and Standards (Food Products Standards and Food additives) Regulations, 2011 for bringing down the maximum limit of transfat from 10% to 5% of the food products, issued for seeking public comments.
ix) Online Food Product Approval System launched on 9/9/2014.
x) A Task Force constituted to draft Regulations for Product Approval in September, 2014.
xi) A Committee has also been constituted for undertaking comprehensive review of the Food Safety and Standards Act, Rules and Regulations made thereunder.
22. Central Drugs Standard Control Organization
a. Strengthening of Drug Regulatory System in the country under 12th Five Year Plan
In the 12th Five Year Plan, it has been proposed that Drug Regulatory mechanism in terms of infrastructure, both physical and human resources at the Centre and the States/ UTs are strengthened.
For strengthening the Central Drug Regulatory system, the revised outlay provides an outlay of Rs. 1058.68 crores for strengthening of infrastructure of CDSCO for so as to enable it effectively discharging various functions of the Central Drug Regulatory System. The Government recommended Rs. 250 crore for introduction of information technology enabled services at CDSCO for the purpose of discharging various functions assigned to it.
For strengthening the State Drug Regulatory mechanism, a new centrally sponsored scheme under National Health Mission (NHM) Umbrella has been proposed with 75:25 sharing pattern for providing financial and human resource support to the States / UTs. Under the Scheme there shall be requirement of Rs. 1079 crores, in which the States share would be of Rs. 229 crores and the Central Government share would be of Rs. 850 crores. The components of expense heads approved relates to up-gradation of State Labs, expansion of existing offices, manpower accommodation and creation of new labs or mobile labs.
b. Prof. Ranjit Roy Chaudhury Expert Committee
An Expert Committee was constituted by the Ministry of Health and Family Welfare under the Chairmanship of Prof. Ranjit Roy Chaudhury to formulate policy and guidelines for approval of new drugs, clinical trials and banning of drugs. The Committee in its report made a number of recommendations in respect of regulating the conduct of clinical trials in the country in a most authentic and transparent way. The recommendations included accreditation of Ethics Committees, investigators and clinical trial sites, procedures to be followed for review and grant of permissions for clinical trials, use of information technology to ensure transparency in the system, establishing a system of reporting of serious adverse events and compensations in case of injury or death related to clinical trials etc. Majority of the recommendations have been accepted by the Government and actions initiated. These measures will ensure that data generated in the clinical trials is authentic while the rights of human subjects participating in the trial are well protected.
c. National Survey on to assess the prevalence of spurious substandard drugs
An All India Survey is proposed to be conducted in the country with methodology prepared by Indian Statistical Institute, Hyderabad to assess the prevalence of spurious and sub-standard drugs in the country. In the proposed survey, around 42,000 samples would be drawn from across the country which would include 15 therapeutic categories of drugs which is listed in National List of Essential Medicines (NLEM), 2011.The exact quantity of drugs to be sampled will be finalized after discussion with Indian Statistical Institute (ISI), Hyderabad and National Sample Survey Office (NSSO), Delhi. The proposed survey is to be conducted in the year 2014 and 2015. In order to conduct the survey effectively the State Drug Inspectors, participating in the survey will be identified, trained by the National Institute of Biologicals, Noida.
d. Revision of National List of Essential Medicines (NLEM), 2011
The National List of Essential Medicines (NLEM) is one of the key instruments in balanced healthcare delivery system of a country which inter alia includes accessible, affordable quality medicine at all the primary, secondary, tertiary levels of healthcare. NLEM was last revised in 2011.
A core committee has been constituted by the Government under the Chairmanship of Dr. V. M. Katoch, Secretary, HR & DG, ICMR for updating the NLEM, 2011. The committee has met three times and has prepared guidelines for revision of NLEM, 2011. The National consultations are in progress for the purpose of finalization revision of NLEM.
e. Banning of drugs
Drugs about which reports are received that these are likely to involve risk to human beings or animals in the present context of the knowledge are examined for their safety and rationality through the expert committees and / or DTAB after due examination of their rationality and safety. Following drugs were prohibited during the period.
a. ‘Dextropropoxyphene and formulations containing Dextropropoxyphene for human use’ (G.S.R. 332(E) dated 23.05.2013).
b. ‘Fixed dose combination of flupenthixol + Melitracen for human use’ (G.S.R. 377(E) dated 18.06.2013) and 498(E) dated 11.07.2014.
c. Restriction of sale of Oxytocin bulk to licensed manufacturers only and sale of vet. Oxytocin injection to veterinary hospitals only (GSR 29(E) dated 17.01.2014).
d. Analgin and all formulations containing analgin for human use to be marketed for restricted indications only (GSR 86(E) dated 13.02.2014).
f. Prohibition of testing of cosmetics on animals
The Drugs and Cosmetics Rules, 1945 has been amended vide Gazette notification G.S.R. 346(E) dated 21.05.2014 prohibiting the testing of cosmetics on animals in the country. The rules were further amended to prohibit import of cosmetics tested on animals vide Gazette notification G.S.R. 718(E) dated 13.10.2014.
g. Clinical Trials
Various initiatives have been taken for further strengthening of clinical trial regulation to ensure the protection rights, safety and wellbeing of Clinical Trial subjects and authenticity of bio medical data generated. Some of the initiatives are given below:-
i. Following amendments have been made under the Drugs and Cosmetics Rules for strengthening the regulations relating to clinical trials.
a. Rule 122 DAB was introduced on 30.01.2013 specifying requirements for providing medical management in case of injury and payment of compensation in case of trial related injury or death (G.S.R. 53(E)).
b. Rule 122 DAC was introduced on 01.02.2013 specifying conditions for conduct of clinical trials (G.S.R. 63(E)).
c. Rule 122 DD was introduced relating to registration of Ethics Committees by the office of DCG (I) (G.S.R. 72(E)).
ii. A system of supervision of procedure for grant of clinical trial has been put in place by constituting an Apex Committee under Chairmanship of Secretary, Health and Family Welfare and a Technical Committee under Chairmanship of DGHS in compliance to the Hon’ble Supreme Court’s order dated 03.01.2013,.
iii. The procedure now followed for review of Clinical trial applications is a three tier review process. The applications are first evaluated by the New Drugs Advisory Committees (NDACs)/ Investigational New Drugs (IND) committee. The recommendations of these committees are reviewed by the Technical Committee and then approved by the Apex Committee.
iv. It has been made mandatory with effect from 30.11.2013 that in all clinical trials, in addition to the requirement of obtaining written informed consent, audio-visual recording of the informed consent process of each trial subject, is required to be done as per directions of the Hon’ble Supreme Court on 21.10.2013,. The Drugs and Cosmetics Rules, 1945 are also being amended to make audio-video recording mandatory before enrolling the clinical trial subjects.
v. An Expert Committee has been constituted to examine the reports of deaths in clinical trials. The committee has prepared a formula for determining the quantum of compensation in case of clinical trial related deaths which is available in CDSCO website.
vi. Expert committees have also been constituted for examination of Serious Adverse Events related to clinical trials.
h. Strengthening of Central Drug Testing Laboratories
For strengthening the testing capacities of the Central Drug Testing Laboratories, an amount of Rs. 12,84,77,206/- was sanctioned on account of procurement of various equipments for these laboratories.
i. Quality assurance and patient safety
In the 47th meeting of the Drugs Consultative Committee meeting held in July, 2014 it was decided that inspections of drug manufacturing unites will be exhaustive and for both Good Manufacturing Practices (GMPs) as well as Good Laboratory Practices (GLPs) to ensure quality production of Drugs in the country.
It was also decided that State Drugs Controllers should focus on patient safety and rules should be implemented in such a way that it is ensured that safe and efficacious drugs are made available to the patients.
Further, in the special DCC meeting held on 27.10.2014 it has been resolved that the States / UTs Drug Regulatory Authorities will also have mission and vision adopted by the CDSCO earlier.
The mission is: ‘to safeguard and enhance the public health by assuring the safety, efficacy and quality of drugs, cosmetics and medical devices.’
23. Strengthening nursing services
a. The Centrally Sponsored Scheme is for Strengthening/Upgradation of Nursing Services with funding pattern of 85% by Central Government and 15% by the State Government for starting new ANM/GNM Nursing Schools is proposed to be continued during 12th Plan Period. The EFC for the scheme was held on 2nd April, 2014.
The Government has initiated action for the opening of 132 Auxiliary Nurse Midwife (ANM) and 137 General Nursing Midwifery (GNM)) schools in those districts of 23 high focus states the country where there is no such school. This will create 13500 additional intake capacities of candidates per year. So far 127 ANM schools and 137 GNM schools have been approved across the Country.
b. The Central Sector Scheme aims at the Development of Nursing Services by way of Training of Nurses, upgradation of School of Nursing into College of Nursing and by giving Florence Nightingale National Awards, is proposed to be continued during 12th Plan Period. The SFC of the Scheme was held on 19th September, 2014.
c. A Nursing and Midwifery Portal was launched on June 13. It is an online resource centre for the state nursing councils and the entire nursing and midwifery cadre. Such a resource centre makes it possible to being all stakeholders in the health ecosystem –nurses, midwives, students, state nursing councils, Indian Nursing Council, the Ministry – on a common platform.
24. Capacity Building for developing Trauma Care Facilities on National Highways
– The pre-hospital trauma technician course curriculum has been revised and the revised curriculum is being implemented in the three Central Government Hospitals in Delhi namely Dr. RML Hospital, Safdarjung Hospital and LHMC, for training of pre-hospital trauma technicians to be posted in ambulances (ALS/BLS) all over the country.
– National Injury Surveillance Centre has been established at Dr. RML Hospital, New Delhi.
25. National Health Portal
The National Health Portal (NHP) (http://nhp.gov.in) has been launched on 14.11.2014. NHP will serve as a gateway to authentic health information for all and for providing authenticated health information for citizens, students, healthcare professionals and researchers. Now, the NHP is disseminating information in Hindi, Gujarati, Bangla, Tamil and English.
Department of Health Research
1. Department of Health Research (DHR) has taken following steps to launch the affordable indigenously developed technologies:
i) Technologies launched:-
§ Indigenous strips and detection system(s) for diabetes mellitus (13th Jan,2014)
§ New test for detection of pathogenic bacteria in food and Technologies for Vitamin A and Ferritin estimations (20th Feb, 2014)
§ Novel non-invasive methods for diagnosis of visceral leishmaniasis (Kala-Azar) by rK39 testing of sputum/ urine samples: launched on 2nd September, 2014. This disease strikes in Bihar, Jharkhand, West Bengal and Uttar Pradesh.
ii) Technologies which are ready for launch:
§ Diagnostic kit for lung fluke disease (Paragonimiasis) – developed by Regional Medical Research Centre (RMRC), Dibrugarh, Assam. Lung Fluke is often confused with TB.
§ Diagnostic kits for Leptospirosis developed by RMRC, Port Blair. This disease is prevalent in Karnataka, Gujarat and Tamil Nadu.
§ Diagnostic kits developed by NIRRH, Mumbai to detect Chlamydial infection which is a reproductive tract infection (RTI) prevalent in women.
§ Kits for Hormone Assays developed by NIRRH Mumbai; useful for reproductive health problems, with the potential of reducing costs.
§ Cooling jacket developed by NIOH, Ahmedabad for prevention against exposure to high temperatures particularly in industrial workforce.
iii) Other important technologies initiated:-
— New rapid molecular methods for detection of drug resistance in TB
— New test methods for diagnosis of chikunguniya, Crimean-Congo Haemorrahagic fever, dengue.
— An immune-chromatographic dipstick kit for cholera, biocides for mosquito control, rapid test for assessing osteoporosis, ergonomic cycle rickshaw developed by ROHC (NIOH), Kolkata , non-invasive test for diabetes, test for glycosylated haemoglobin, genomic chips for cancer diagnosis and classification.
2. Research Programme on Environmental and Occupational Health launched to monitor the effects of pesticides on human and animal health.
3. Decision to establish National Institute for Research on Environmental Health at Bhopal with focus on robust research in managing health programmes caused by chemical exposure.
4. DHR has developed a knowledge management policy to use e-connectivity provided by National Knowledge Network for improving the service, education and research in health. Model projects have been developed by state medical institutions in north India to demonstrate the usefulness of this policy framework to be launched shortly.
5. ICMR has also developed a conceptual framework for joint research with the Ministry of Environment and Forests, Indian Council of Agricultural Research and other institutions to find solutions to water, soil and air pollution. At least 20 projects as Inter-departmental/ inter-ministerial research cum action programmes are targeted.
6. ICMR has developed a blueprint for research-cum-action on disabilities prevention and management. An institution framework will be announced shortly.
7. Legislation:
DHR/ICMR has prepared the following three Bills for introduction in Parliament during winter session of 2014:
a) The Biomedical and Health Research Regulation Bill, 2014 (to deal with Ethical Issues pertaining to entire Biomedical Research other than trials on new drugs/ vaccines/ devices on human subjects)
b) Assisted Reproductive Technology (Regulation) Bill 2014 (to regulate medical, social, ethical and legal aspects of surrogacy in the country)
c) The Recognition of New Systems of Medicine Bill 2014 (to regulate the process for recognition of any proposed new systems of medicine)
8. Strengthening of infrastructure and human resource to promote Biomedical and health research in the country:
— 7 Model Rural Health Research Units (MRHRUs) approved for Karnataka, Punjab, Maharashtra, Odisha, Chattisgarh, Madhya Pradesh and Andhra Pradesh to focus on research on disease specific rural issues and to introduce new technologies into rural health care.
— 16 Multi-disciplinary Research Units (MRUs) have been approved in government medical colleges focused on NCDs and health of women & child. Further seven units earlier approved have already become functional during the year.
— 29 Virology Diagnostic Research Labs (VDRLs) 3 Regional labs + 5 State Level Labs + 21 Medical College level labs for research on viral diseases in different States were approved during this period.
— Upgradation to Regional Medical Research Centre (RMRC) at Gorakhpur
SFC proposal submitted. For upgradation of NIV Pune at Gorakhpur unit this centre will carry out research on communicable, non-communicable, maternal and child health, nutrition, environmental and other aspects relevant to region.
— A Centre for Policy Research on Vaccine Preventable Diseases
An MoU has been signed with DBT, Deptt of Health & Family Welfare and Department of Health Research/ICMR. The centre will generate evidence with regard to vaccines for public health policy as well as play an advisory role with regard to vaccines that may not be included for use in national programme but will be available to public.
— Samrat Ashok Tropical Disease Research Centre at RMRI, Patna
A 200 bedded hospital for research on tropical diseases is ready for inauguration soon.
— Establishment of Medical/Health Technology Assessment Board for Technology Choice:
With aim to develop guidelines and provide guidance for introduction of cost-effective technologies/strategies for public health for reducing expenses on health care.
Department of AIDS Control
1. Country’s Plasma Policy announced – The National Policy for Access to Plasma Derived Medicinal Products from Human Plasma for Clinical/ Therapeutic Use was announced on World Blood Donors Day (14 June 2014). The Policy aims at making available, easily accessible and adequate supply of high quality plasma derived proteins for clinical/therapeutic use. It aims to enable mobilization of excess plasma stocks from blood banks to the plasma fractionation units in order to obtain higher value products that can be made available for clinical and therapeutic use.
2. On World AIDS Day, Toll free National AIDS Helpline was launched along with India HIV/AIDS Resource Centre and Inventory management system and Prevention of Parent to Child Transmission (PPTCT) campaign.
3. Sexually Transmitted Infection Division at NACO and RMNCH+A division at NRHM jointly revised and released the National Guidelines on STI/RTI Control and Prevention in August, 2014.
4. 45 HIV laboratories (National and State Reference Laboratories) attained NABL accreditation till date.
5. National AIDS Control Organisation has signed 11 MoUs with Ministries/ Departments for mainstreaming HIV/AIDS.
6. 30 new Opioid Substitution Therapy (OST) centres established in Government health facilities
7. A National Working Committee on HIV/ AIDS and Prison Intervention and Law enforcement agencies with representatives from the Narcotics Control Bureau, MSJE, police training academies, etc., has been formed with Secretary (Health) as the Chairperson to plan and implement HIV/AIDS prevention and care in prison setting in India.
8. Published National Framework for HIV/TB collaborative activities in India, PPTCT National -Guidelines & National Strategic Plan of PPTCT and disseminated to SACS.
9. Integrated Induction Training and refresher training module for counselors under NACP – Developed
10. National TB/HIV coordination committee meeting and National Joint review meetings of States & UTs for HIV/ TB held.
11. 677 New ICTCs including F-ICTC’s, PPP & Mobile ICTC’s established during 2014-15
12. Assessment of Prevention of Parent to Child Transmission of HIV (PPTCT) services implementation in States of Andhra Pradesh, Telangana, Karnataka and Tamil Nadu.
13. NACO Condom Social Marketing Program implementation was concluded in 11 states (UP, Uttarakhand, AP, MP, Delhi, Bihar, Jharkhand, Chhattisgarh, Goa, Punjab, Haryana & Chandigarh) covering 224 districts.
14. NACO Condom Social Marketing Program implementation was rolled out in 12 new states (Karnataka, Rajasthan, Gujarat, Maharashtra, West Bengal, Odisha, Assam, Nagaland, Manipur, Mizoram, Meghalaya & Tripura) covering 171 districts.
15. Conducted Condom Quality Audit to determine the quality of different condom brands available at retail outlets across the country. Findings reiterated that GoI condom brands i.e. Nirodh (free supply) and Deluxe Nirodh (Socially Marketed) are at par with the best of commercial brands in terms of quality.
16. Special communication drives for migrants were carried out in program states during Diwali and Durga Puja festivals across 18 program states.
17. For care and support, new guidelines adopted as per WHO guidelines. Also, newer initiatives like pharmacovigilance, early warning indicator and quality care indicators analysis done to improve quality of care for patients living with HIV-AIDS.CCI Newswire
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…